BINV — Brandes International ETF

Is BINV overbought or oversold? Here is the current MarketMoodz read.

Oversold As of October 3, 2026

Brandes International ETF (BINV) currently reads Oversold on the MarketMoodz overbought/oversold meter, as of October 3, 2026. The stock last closed at $42.74. The rating moved from Neutral to Oversold on September 30, 2026.

AI analysis

Brandes International ETF (BINV) delivers diversified, value-tilted exposure to global equities outside the U.S. Near-term performance is likely to track broader risk-off sentiment, geopolitical headlines, and currency moves. Outcomes over the next month will hinge on global earnings momentum, risk sentiment, and currency stability.

Key factors

  • Broad non-U.S. equity exposure with value orientation provides diversification beyond U.S. markets
  • Current market tone is risk-off and defensive flows may limit near-term inflows to international equities
  • ETF structure offers intraday liquidity and typically lower single-stock concentration risk versus active funds
  • Potential for income and downside cushion if underlying holdings pay dividends
  • Currency fluctuations and global macro developments materially influence returns
  • Lack of immediate sector/theme tailwinds and limited fresh catalysts in the near term

Risks

  • Geopolitical tensions and supply-chain uncertainty can depress non-U.S. equity performance
  • Foreign exchange volatility could amplify losses for USD-based investors
  • Exposure to countries with weaker earnings growth or political risk
  • Rising global rates or tightening financial conditions could pressure value and cyclical international names
  • Light trading volumes and limited recent news flow reduce conviction and can increase short-term volatility
  • Lack of recent filings or social/research signals increases information asymmetry

See today's live rating, score and targets

Members see the live hourly rating for BINV — the numeric AI score plus targets and entry zones — while this public page updates nightly.

Start the 14-day trial

This page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.